Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pressure Biosciences Inc PBIO

Pressure BioSciences, Inc. is engaged in providing broadly enabling, high pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical, and agrochemical, as well as food and beverage manufacturing. The Company's enabling platform, Pressure Cycling Technology (PCT), utilizes alternating cycles of pressure to control bio-molecular... see more

OTCQB:PBIO - Post Discussion

Pressure Biosciences Inc > Pressure BioSciences Invites Interested Investors to Attend
View:
Post by averagepennies on Aug 17, 2023 10:52am

Pressure BioSciences Invites Interested Investors to Attend

Webinar Scheduled for 11:00AM ET on Thursday, August 17; Nearly 500 Registrants to Date.

SOUTH EASTON, MA / ACCESSWIRE / August 17, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, food & beverage, pharmaceuticals, biotherapeutics, agrochemical, and other industries today announced that the Company's President and CEO (Mr. Richard T. Schumacher) and Director of Marketing & Sales (Mr. John B. Hollister) are the featured speakers at an online webinar scheduled for 11am ET on Thursday, August 17, 2023.

The webinar is entitled: "Health and Wellness Innovations: The Marvels of UltraShear™". During this webinar, you can expect to:

  1. Gain a quick overview of Pressure BioSciences Inc. (OTCQB: PBIO) and its core technologies and products.
  2. Learn about the powerful UltraShear platform and why it is viewed as a "Best-in-Class" processing system.
  3. Explore UltraShear's transformative impact through its multiple applications in health & wellness.
  4. Be inspired by life-changing experiences enjoyed by users of products processed by the UltraShear platform.
  5. Have your questions answered during our interactive Q&A session.

Don't miss out on this chance to be part of the future of innovation in Health and Wellness! Register here to secure your spot and learn more about the webinar:PBIO Aug 17 Webinar Registration.

PBIO Recent News and Accomplishments

  • PBIO Reports Strongly Accelerating UltraShear Nano-CBD orders.
  • PBIO to Evaluate Company's Patented UltraShear Process to Extend Shelf-Life of Fresh Produce.
  • PBIO's UltraShear Nano-CBD Commercial Rollout Program Enters Rapid Expansion Phase 2.
  • Company Announces Nano-CBD Topical Spray Distribution Agreement with Crme de Canna.
  • Key Academic Publication Further Validates PBIO's UltraShear Platform's Impact on Clean-Label Foods.
  • PBIO Partners with Somalab Int'l for Development and Distribution of UltraShear-enabled health products.
  • Consumer Testing Validates Rapid Absorption/Effectiveness of UltraShear Nano-THC Spray
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities